Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03566615
Other study ID # ASGE 2016 International Award
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date January 31, 2023

Study information

Verified date October 2022
Source VA Greater Los Angeles Healthcare System
Contact Vivek Dixit, PhD
Phone 818-895-9426
Email vivek.dixit@va.gov
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a study to compare two different, but normally, used methods of colonoscopy in patients that require a routine or repeat colonoscopy. There will be three arms in this study: WE water control, water plus Cap-1, and water plus Cap-2. The patient will prepare himself/herself for the colonoscopy as per normal instructions and he/she will be given the information for the study at that time so that he/she can make a decision to participate in the study. The control method will use water instead of air inserted into the colon. The study method will use a new accessory, a cap that will fit onto the end of the colonoscope plus water during the procedure. This study will also confirm if using the cap method with water is a better way of detecting polyps in the colon and possibly cancer.


Description:

This will be a multi-site, multi-national, unblinded investigators, prospective Random Control Trial (RCT). Randomization (WE, WE Cap-1, WE Cap-2) will be based on computer generated random numbers placed inside opaque sealed envelopes. The envelope (in pre-arranged order) will be opened to reveal the code when the colonoscopist is ready to insert the endoscope to begin the examination. This will be a comparison of two different methods with three arms (WE, WE Cap-1, WE Cap-2) to see which one is better at detecting adenomas. Patients who are willing to participate will sign an informed consent before starting the colonoscopy procedure. Separate parallel randomization will be set up at each site, stratified by investigator and type of colonoscopy (screening or surveillance). Mode of sedation will include unsedated (China, US West Los Angeles VA), minimally sedated (Taiwan), on demand sedation (Italy, Czech Republic, US West Los Angeles VA), conscious sedation (US Sacramento VA and Palo Alto VA) or full sedation with propofol (Taiwan). Randomization (prepared by statistics consultant) will be carried out by the method of random permuted block design (based on computer generated random numbers) with variable block sizes of 3 and 6. Gender will be used as a stratification factor. Control Method: One arm of the study will include sedated/unsedated colonoscopy with water (WE) as the control method. Residual air in the colon will be removed and water will be infused to guide insertion through an airless lumen. Infused water will be removed by suction, along with residual fecal debris, predominantly during insertion. Study method: The other two arms entail the addition of a simple commercially available accessory to the colonoscopy device: Cap -1 (Disposable Distal Attachment) or Cap-2, fitted to the colonoscope per manufacturer instruction. The two arms include sedated/unsedated colonoscopy with either a Cap-1 plus water or Cap-2 plus water.


Recruitment information / eligibility

Status Recruiting
Enrollment 1630
Est. completion date January 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria: 1. Male and female 50-75 yrs of age. 2. Positive screening for Fecal Immunochemical Test (FIT) or Fecal Occult Blood Test (FOBT). 3. Subjects willing to undergo routine screening and surveillance colonoscopy. Exclusion Criteria: 1. Patients who decline to provide informed consent. 2. Patients known to have colonic obstruction, inflammatory bowel disease, or active GI bleeding requiring interventions. 3. Patients know to have prior history of severe diverticulitis/diverticulosis.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CAP-straight
This study is to detect any differences in the detection rate of adenomas using straight caps that will be attached to the colonoscope and to compare it to the control method where no cap is used in the colonoscopy procedure.
CAP-daisy
This study is to detect any differences in the detection rate of adenomas using daisy caps that will be attached to the colonoscope and to compare it to the control method where no cap is used in the colonoscopy procedure.
Other:
water
using water instead of traditional air insufflation to help insertion

Locations

Country Name City State
China Xijing Hospital of Digestive Diseases Xian
Italy St. Barbara Hospital Iglesias
Taiwan Dalin Tzu Chi General Hospital Chiayi City
Taiwan Hualien Tzu Chi Hospital Hualien City
Taiwan Evergreen General Hospital Taipei
United States Sacramento VAMC, VA Northern California Healthcare System Mather California
United States Veterans Affairs Palo Alto Healthcare System Palo Alto California

Sponsors (2)

Lead Sponsor Collaborator
VA Greater Los Angeles Healthcare System University of California, Los Angeles

Countries where clinical trial is conducted

United States,  China,  Italy,  Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adenoma detection rate The proportion of individuals undergoing a complete screening colonoscopy who have one or more adenomas, or polyps, detected. 2 years
Secondary Cecal intubation Visualization of ileocecal valve/appendix orifice and the medial wall of the cecum with colonoscope tip touching floor of cecum 2 hours: Data collected during colonoscopy procedure
Secondary Boston bowel preparation score Three segments (Right, transverse, left colon), each with 0 to 3 (poor to excellent); total scores = sum (10 point scale) 2 hours: Data collected during colonoscopy procedure
Secondary Cecal intubation time Total time from insertion into the anus to arrival in the cecum 2 hours: Data collected during colonoscopy procedure
Secondary Visual analogue scale (0=not satisfied, 10=very satisfied) Patient satisfaction 2 hours: Data collected during colonoscopy procedure
Secondary Willing to repeat Visual analogue scale (0=not willing, 10=willing) 2 hours: Data collected during colonoscopy procedure
See also
  Status Clinical Trial Phase
Completed NCT04101097 - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed NCT03247595 - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy N/A
Completed NCT04214301 - An Open-Label Preference Evaluation of BLI800 Phase 4
Withdrawn NCT05754255 - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center N/A
Recruiting NCT02484105 - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Phase 4
Active, not recruiting NCT02264249 - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation N/A
Completed NCT01964417 - The Comparative Study Between Bowel Preparation Method Phase 3
Terminated NCT01978509 - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies N/A
Recruiting NCT01685970 - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy Phase 3
Completed NCT01518790 - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children N/A
Recruiting NCT00748293 - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet N/A
Completed NCT00779649 - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial Phase 4
Completed NCT00671177 - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique N/A
Completed NCT00380497 - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children Phase 4
Recruiting NCT00160823 - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients Phase 3
Completed NCT00314418 - Patient Position and Impact on Colonoscopy Time N/A
Completed NCT00390598 - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy Phase 2/Phase 3
Completed NCT00427089 - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Phase 3
Completed NCT00209573 - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy Phase 3
Completed NCT05823350 - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy N/A